Yuan Wu

Yuan Wu


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2019 in BMC Neurology
Verified
Journal Article
Open access
PDF file
MZMing Zhang
Ming Zhang
YZYonglin Zhao
Yonglin Zhao
JZJunjie Zhao
Junjie Zhao
THTingqin Huang
Tingqin Huang
YWYuan Wu
Yuan Wu
Purpose: Glioma is the most common primary malignant brain tumor with high mortality and poor prognosis. Our aim was to clarify the correlation betweenKinase-anchored protein 6(AKAP6) gene polymorphisms and glioma susceptibility and prognosis in Chinese Han population.Methods: Five single-nucleotide polymorphisms (SNPs) ofAKAP6were genotyped by Agena MassARRAY in 575 glioma patients and 500 healthy controls. Logistic regression model was utilized to calculate odds ratios (OR) and 95% confidence intervals (CI). The associations between polymorphisms and survival were assessed using the log-rank test, Kaplan-Meier analysis and Cox regression model.Results: We found that rs2239647 polymorphism was strongly associated with an increased risk of glioma (OR = 1.90,p = 0.007) and a worse prognosis for glioma, especially in high-grade glioma (HR = 1.67,p = 0.034). Stratified analysis showed that rs2239647 increased the risk of glioma in female (OR = 1.62,p = 0.016). Whereas, rs4261436 (HR = 0.70,p = 0.045) and rs17522122 (HR = 0.75,p = 0.016) were associated with better prognosis of astrocytoma. In addition, we also found that surgical methods and chemotherapy are critical factors for the prognosis of glioma patients.Conclusions: This study firstly provided evidence for the impact ofAKAP6polymorphisms on susceptibility and prognosis of glioma, suggestingAKAP6variants might have potential roles in the etiology of glioma.

8 October 2019 in Cancer Medicine
Verified
Journal Article
Open access
PDF file
YWYing Wu
Ying Wu
LZLinghui Zhou
Linghui Zhou
YDYujiao Deng
Yujiao Deng
NLNa Li
Na Li
PYPengtao Yang
Pengtao Yang
YWYuan Wu
Yuan Wu
DNA polymerase kappa (POLK), one of the specialized Y family DNA polymerases, functions in translesion synthesis and is suggested to be related with cancers. Single nucleotide polymorphisms (SNPs) in specialized DNA polymerases have been demonstrated to be associated with cancer risk. To evaluate the association of two common POLK variants (rs3213801 C>T and rs5744533 C>T) with glioma, we conducted a case‐control study and genotyped these two POLK variants in 605 patients and 1300 healthy controls. The association analysis revealed no significant correlations were observed between these two POLK SNPs and glioma risk. However, the POLK rs3213801 CT genotype was found to be higher in older glioma patients (≥40) than in younger patients (P = .026). Compared with patients harboring the CC genotype, the frequencies of POLK rs5744533 CT and CT+TT genotypes were increased in patients with lower World Health Organization (WHO) grade glioma (P = .028, 0.044, respectively). According to Kaplan‐Meier analysis and log‐rank tests, POLK SNPs were not correlated with either the overall survival or progression‐free survival. Nevertheless, multivariate analysis revealed that the age (≥40) could increase the risk of death in glioma patients (P < .05), while gross‐total resection and temozolomide treatment were found to play protective roles in glioma prognosis (P < .001, respectively). Overall, our results indicated that POLK variants rs3213801 and rs5744533 are not associated with glioma risk and prognosis. However, these polymorphisms are likely to be associated with certain glioma characteristics, such as age and WHO grade. The age, surgery types, and chemotherapy could be independent prognostic factors in glioma. More studies are required to confirm our findings.

28 April 2026 in Virology Journal
Verified
Journal Article
Open access
PDF file
CWChengyu Wang
Chengyu Wang
HGHuangxin Gong
Huangxin Gong
JWJiatian Wang
Jiatian Wang
TYTing Yang
Ting Yang
YWYuan Wu
Yuan Wu
YCYan Cai
Yan Cai
The incidence of Coronavirus Disease 2019 (COVID-19) pneumonia-associated Invasive Fungal Infections (IFI) has risen markedly. However, current evidence re

28 June 2019 in Research Square
Verified
Preprint
Open access
MZMing Zhang
Ming Zhang
YZYonglin Zhao
Yonglin Zhao
JZJunjie Zhao
Junjie Zhao
THTingqin Huang
Tingqin Huang
XGXiaoye Guo
Xiaoye Guo
YWYuan Wu
Yuan Wu
Purpose Glioma is the most common primary malignant brain tumor with high mortality and poor prognosis. Our aim was to clarify the correlation between AKAP6 gene polymorphisms and glioma susceptibility and prognosis in Chinese Han population. Methods Five single-nucleotide polymorphisms (SNPs) of AKAP6 were genotyped by Agena MassARRAY in 575 glioma patients and 500 healthy controls. Logistic regression model was utilized to calculate odds ratios (OR) and 95% confidence intervals (CI). The associations between polymorphisms and survival were assessed using the log-rank test, Kaplan-Meier analysis and Cox regression model. Results We found that rs2239647 polymorphism was strongly associated with an increased risk of glioma (OR = 1.90, p = 0.007) and a worse prognosis for glioma, especially in high-grade glioma (HR = 1.67, p = 0.034). Stratified analysis showed that rs2239647 increased the risk of glioma in female (OR = 1.62, p = 0.016). Whereas, rs4261436 (HR = 0.70, p = 0.045) and rs17522122 (HR = 0.75, p = 0.016) were associated with better prognosis of astrocytoma. In addition, we also found that surgical methods and chemotherapy are critical factors for the prognosis of glioma patients. Conclusions This study firstly provided evidence for the impact of AKAP6 polymorphisms on susceptibility and prognosis of glioma, suggesting AKAP6 variants might have potential roles in the etiology of glioma.

16 October 2019 in Research Square
Verified
Preprint
Open access
MZMing Zhang
Ming Zhang
YZYonglin Zhao
Yonglin Zhao
JZJunjie Zhao
Junjie Zhao
THTingqin Huang
Tingqin Huang
YWYuan Wu
Yuan Wu
Purpose Glioma is the most common primary malignant brain tumor with high mortality and poor prognosis. Our aim was to clarify the correlation between AKAP6 gene polymorphisms and glioma susceptibility and prognosis in Chinese Han population. Methods Five single-nucleotide polymorphisms (SNPs) of AKAP6 were genotyped by Agena MassARRAY in 575 glioma patients and 500 healthy controls. Logistic regression model was utilized to calculate odds ratios (OR) and 95% confidence intervals (CI). The associations between polymorphisms and survival were assessed using the log-rank test, Kaplan-Meier analysis and Cox regression model. Results We found that rs2239647 polymorphism was strongly associated with an increased risk of glioma (OR = 1.90, p = 0.007) and a worse prognosis for glioma, especially in high-grade glioma (HR = 1.67, p = 0.034). Stratified analysis showed that rs2239647 increased the risk of glioma in female (OR = 1.62, p = 0.016). Whereas, rs4261436 (HR = 0.70, p = 0.045) and rs17522122 (HR = 0.75, p = 0.016) were associated with better prognosis of astrocytoma. In addition, we also found that surgical methods and chemotherapy are critical factors for the prognosis of glioma patients. Conclusions This study firstly provided evidence for the impact of AKAP6 polymorphisms on susceptibility and prognosis of glioma, suggesting AKAP6 variants might have potential roles in the etiology of glioma.